NCT07158879 Skin Reactions Related to Thoracic Implantable Chamber Dressings
| NCT ID | NCT07158879 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Curie |
| Condition | Skin Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-06-10 with a primary completion date of 2026-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age * New chemotherapy patients (1st line of treatment only) * Thoracic PAC Exclusion Criteria: * PICC Line and femoral PAC; * Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp); * Disunion requiring treatment * Patients treated for hematological cancer; * Persons deprived of their liberty or under guardianship (including curatorship); * Adults under court protection; * Inability to participate in the study for geographical, social or psychological reasons. * No inclusion of persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.). * Opposition to data use
Contact & Investigator
Betty LIMIER
PRINCIPAL INVESTIGATOR
Institut Curie
Frequently Asked Questions
Who can join the NCT07158879 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Skin Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07158879 currently recruiting?
Yes, NCT07158879 is actively recruiting participants. Contact the research team at betty.limier@curie.fr for enrollment information.
Where is the NCT07158879 trial being conducted?
This trial is being conducted at Paris, France, Pirae, French Polynesia, Uturoa, French Polynesia.
Who is sponsoring the NCT07158879 clinical trial?
NCT07158879 is sponsored by Institut Curie. The principal investigator is Betty LIMIER at Institut Curie. The trial plans to enroll 500 participants.